Front Page Demo Slide


LATEST NEWS:   Shire's CFO resigns to join plant technology start-up - LONDON (Reuters) - Pharmaceutical company Shire said its chief financial officer Jeff Poulton will stand down at the end of the year to join Indigo Ag, a Boston-based start-up that seeks to improve agricultural productivity.
LATEST NEWS:   Belgian biscuit maker recalls products amid contaminated eggs scare: TV - BRUSSELS (Reuters) - Belgian biscuit maker Lotus Bakeries has recalled some of its products as they could contain eggs that were contaminated with insecticide fipronil, broadcaster VTM said on Monday.
LATEST NEWS:   Britain's Creo receives speedy FDA approval for its endoscopic device - LONDON (Reuters) - Britain's Creo Medical Group said its device to remove cancerous lesions in the bowel during an endoscopy had received U.S. approval much quicker than it planned, shaking up a timetable that had been focused on a European launch.
LATEST NEWS:   AstraZeneca ups investment in messenger RNA drugs with Ethris deal - FRANKFURT (Reuters) - AstraZeneca has stepped up its investment in messenger RNA drugs, a promising approach in genetic therapy, by spending more than 25 million euros ($29 million) on a research alliance with German biotech start-up Ethris.
LATEST NEWS:   In health push, Singapore gets soda makers to cut sugar content - SINGAPORE (Reuters) - Singapore's prime minister has urged people to drink water, eat wholemeal bread and choose brown rice over white in a health push that began with an agreement from soda makers to reduce the sugar content in drinks sold in the country.
LATEST NEWS:   New Novartis drug takes aim at tough-to-treat malaria - LONDON (Reuters) - Novartis is taking aim at drug-resistant malaria – a growing global problem – by launching clinical trials of the first new antimalarial medicine for many years in nine countries across Africa and Asia.
LATEST NEWS:   U.S. study revives argument over mammogram screening - (Reuters Health) - Yearly mammograms starting at age 40 would prevent the most deaths from breast cancer, U.S. researchers reported on Monday in a challenge to more conservative recommendations that take into account both the harms and the benefits of screening.
LATEST NEWS:   Samsung Bioepis teams up with Takeda to develop original biotech drugs - SEOUL (Reuters) - Samsung Bioepis Co Ltd said on Monday it will fund and develop multiple original drugs in partnership with Japan's Takeda Pharmaceutical Co Ltd, expanding its business scope beyond copies of existing biologic drugs.
LATEST NEWS:   Drugmaker Hikma's U.S. unit raises medicine prices: Financial Times - NEW YORK (Reuters) - Hikma Pharmaceuticals Plc's U.S. subsidiary has raised the price of a common diarrhea drug by more than 400 percent and is charging more for five other medicines as well, the Financial Times reported on Sunday.